Giuseppe U.
- Country
- Italy
- Department
- UO Cardiologia
Research Overview
Data & Insights
Has run more than one trial at 1 of 26 partner sites.
Specializations
Cardiovascular disease and thromboembolic prevention
Clinical research activity includes atrial fibrillation, ischemic stroke, transient ischemic attack, venous thromboembolism, and broader atherosclerotic cardiovascular disease, with a strong focus on reducing major vascular events and improving long-term cardiovascular protection.
- Stroke prevention
- Anticoagulation alternatives
- Cardiovascular risk reduction
- Secondary prevention of embolic events
Interest also extends to hypertension, high cardiovascular risk, and established vascular disease, reflecting involvement in therapies aimed at preventing recurrent cardiovascular complications.
Heart failure and cardiac inflammation
The investigator is involved in studies addressing heart failure, low-cardiac output syndrome, acute myocarditis, and severe cardiac inflammation, with attention to clinical strategies that support myocardial recovery and hemodynamic stability.
- Heart failure management
- Myocarditis treatment
- Perioperative cardiac support
- Amyloid cardiomyopathy
Research also includes transthyretin amyloid cardiomyopathy and chemotherapy-induced cardiotoxicity, showing engagement with both primary cardiac disease and treatment-related cardiac injury.
Ovarian cancer and gynecologic oncology
A major therapeutic area is ovarian cancer, including advanced epithelial ovarian cancer, platinum-sensitive relapsed disease, platinum-resistant ovarian cancer, and low-grade serous ovarian carcinoma, alongside related fallopian tube and primary peritoneal cancers.
- Maintenance therapy
- Homologous recombination deficiency
- FRα-targeted treatment
- Recurrent gynecologic malignancies
Clinical interests also cover endometrial cancer and locally advanced cervical cancer, with emphasis on targeted and maintenance approaches in gynecologic malignancies.
Breast cancer and solid tumor therapeutics
Research participation includes breast cancer, metastatic triple-negative breast cancer, HER2-positive disease, and high-risk hormone receptor-positive breast cancer, with attention to treatment strategies that address residual risk and metastatic progression.
- Targeted breast cancer therapy
- Endocrine-based treatment
- Metastatic disease control
- Adjuvant and maintenance approaches
Additional activity includes non-small cell lung cancer, metastatic colorectal cancer, and other advanced solid tumors, indicating involvement in oncology programs centered on disease control and treatment selection.
Renal disease, infectious disease, and perinatal care
The investigator also contributes to studies in immunoglobulin A nephropathy, chronic kidney disease associated with cardiovascular burden, and Clostridioides difficile infection, reflecting interest in non-oncologic therapeutic domains.
- Proteinuria reduction
- Renal function preservation
- Infection recurrence prevention
- Perinatal management of PROM
Clinical involvement also includes pre-labor rupture of membranes and influenza prevention, showing a broader therapeutic scope across maternal-fetal medicine and preventive care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.